Jen Kai Fang
Papers
1
Total Citations
4
H-Index
1
About
Dr. Jen Kai Fang is a leading urologic oncologist whose research focuses on upper tract urothelial carcinoma (UTUC), a malignancy with particularly high prevalence in Taiwan. His major contributions center on optimizing surgical management strategies for this challenging disease, most notably through his work evaluating segmental ureterectomy outcomes. In his landmark 2024 study, part of a Taiwan nationwide collaborative effort, Dr. Fang demonstrated that segmental ureterectomy is a viable nephron-sparing option for selected patients with mid- and distal ureteral tumors, providing critical evidence from a high-endemic region where such data were previously lacking. This work, which has already garnered 4 citations, addresses a significant gap in the literature by validating National Comprehensive Cancer Network guidelines in an Asian population. Dr. Fang’s research is particularly impactful given Taiwan’s status as a UTUC endemic area, where his findings directly inform clinical decision-making for thousands of patients. His collaborative approach, uniting multiple institutions across Taiwan, exemplifies the power of nationwide research networks in addressing region-specific healthcare challenges.
Research Focus
Key Achievements
Top Papers
- 1